Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1049.68x is 30% above its 5-year average of -1508.08x, near the high end of its 5-year range (-6355.05x–-535.07x).
9.55% above its 12-month average of -1160.47x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -675.00x.
INTEREST COVERAGE RATIO
-1049.68x
INTEREST COVERAGE RATIO AVG TTM
-1160.47x
INTEREST COVERAGE RATIO AVG 3Y
-1283.53x
INTEREST COVERAGE RATIO AVG 5Y
-1508.08x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+9.55%
CURRENT VS 3Y AVG
+18.22%
CURRENT VS 5Y AVG
+30.40%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
-18847.29%
vs the sector median at left
CNS Pharmaceuticals, Inc.
Market Cap
$7.83M
Interest Coverage Ratio
-1049.68x
TTM Avg
-1160.47x
3Y Avg
-1283.53x
5Y Avg
-1508.08x
Market Cap
$7.83M
Interest Coverage Ratio
-97.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.88M
Interest Coverage Ratio
-11.17x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.15M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.24M
Interest Coverage Ratio
-17.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.31M
Interest Coverage Ratio
-924.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CNS Pharmaceuticals, Inc. (CNSP) | $7.83M | -1049.68x | -1160.47x | -1283.53x | -1508.08x |
| GT Biopharma, Inc. (GTBP)vs › | $7.83M | -97.81x | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $7.88M | -11.17x | N/A | N/A | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $8.00M | N/A | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.15M | N/A | N/A | N/A | N/A |
| Longeveron Inc. (LGVN)vs › | $7.47M | N/A | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.24M | -17.73x | N/A | N/A | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -924.78x | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.28M | -11.95x | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.26M | -496.55x | N/A | N/A | N/A |
Interest Coverage
-1049.7x
Debt/Equity
0.00
Current Ratio
5.86
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -675.00x |
| 2026-03-31 | -814.14x |
| 2025-12-31 | -2199.97x |
| 2025-09-30 | -1537.52x |
| 2025-06-30 | -575.72x |
| 2025-03-31 | -698.72x |
| 2024-12-31 | -1153.59x |
| 2024-09-30 | -2492.87x |
| 2024-06-30 | -566.47x |
| 2024-03-31 | -535.07x |
| 2023-12-31 | -1867.19x |
| 2023-09-30 | -2466.72x |
| 2023-06-30 | -1102.85x |
| 2023-03-31 | -906.28x |
| 2022-12-31 | -2235.22x |
| 2022-09-30 | -6355.05x |
| 2022-06-30 | -2212.50x |
| 2022-03-31 | -1227.28x |
| 2021-12-31 | -1247.95x |
| 2021-09-30 | -4026.82x |
| 2021-06-30 | -1619.77x |
| 2021-03-31 | -963.35x |
| 2020-12-31 | -919.62x |
| 2019-12-31 | -697.74x |
| 2019-09-30 | -92.46x |
| 2019-06-30 | -24.94x |
| 2019-03-31 | -11.89x |
| 2018-12-31 | -14.93x |
| 2018-09-30 | -7.29x |
| 2018-06-30 | -30.57x |
| 2018-03-31 | -102.30x |
